Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
for Metastatic Dedifferentiated Liposarcoma
Drug: Peposertib
16 locations incl. Los Angeles
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT05711615·Phase 1·Recruiting